|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.41 CNY | +0.83% |
|
-1.97% | +7.28% |
| Nov. 05 | Novogene Expands UK Offerings with Launch of ONT-Based Whole Plasmid Sequencing Service | CI |
| Oct. 23 | Novogene Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 | CI |
| Capitalization | 5.43B 770M 656M 613M 576M 1.06B 69.73B 1.16B 7.15B 2.77B 32.87B 2.89B 2.83B 120B | P/E ratio 2025 * |
27.7x | P/E ratio 2026 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise value | 5.43B 770M 656M 613M 576M 1.06B 69.73B 1.16B 7.15B 2.77B 32.87B 2.89B 2.83B 120B | EV / Sales 2025 * |
2.41x | EV / Sales 2026 * | 2.16x |
| Free-Float |
24.23% | Yield 2025 * |
0.34% | Yield 2026 * | 0.37% |
| 1 day | +0.83% | ||
| 1 week | -1.97% | ||
| Current month | -2.05% | ||
| 1 month | -8.28% | ||
| 3 months | -17.78% | ||
| 6 months | -4.56% | ||
| Current year | +7.28% |
| 1 week | 13.16 |  | 13.8 |
| 1 month | 13.16 | | 15.08 |
| Current year | 11.02 | | 21.22 |
| 1 year | 11.02 | | 21.22 |
| 3 years | 9.03 | | 41.76 |
| 5 years | 9.03 | | 69.82 |
| 10 years | 9.03 | | 69.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rui Qiang Li
CEO | Chief Executive Officer | 46 | 2011-03-14 |
Shi Shan Shi
DFI | Director of Finance/CFO | 43 | 2016-07-08 |
Qi Feng Wang
PRN | Corporate Officer/Principal | 47 | 2016-07-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Qiang Li
CHM | Chairman | 46 | 2016-07-08 |
Qi Feng Wang
BRD | Director/Board Member | 47 | 2019-01-10 |
Quan Gan
BRD | Director/Board Member | 49 | 2022-06-14 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.83% | -1.97% | -6.49% | -54.43% | 770M | |
| +0.39% | -5.15% | +39.35% | +491.41% | 32.01B | |
| +0.87% | +0.35% | -17.47% | -23.11% | 7.61B | |
| -6.00% | -5.92% | -5.76% | +279.76% | 5.7B | |
| -2.48% | -4.69% | +111.10% | +1,549.73% | 4.38B | |
| -0.37% | -5.12% | -5.43% | +18.44% | 2.65B | |
| -0.36% | -2.75% | -17.63% | -60.83% | 1.83B | |
| +0.68% | -0.42% | -33.80% | -1.33% | 1.53B | |
| -2.01% | +4.07% | +13.30% | +2.15% | 1.52B | |
| 0.00% | -1.44% | +11.50% | -45.15% | 1.3B | |
| Average | -0.85% | -2.22% | +8.87% | +215.67% | 5.93B | |
| Weighted average by Cap. | -0.49% | -3.90% | +25.49% | +400.84% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.25B 320M 272M 254M 239M 441M 28.95B 481M 2.97B 1.15B 13.64B 1.2B 1.17B 49.78B | 2.51B 356M 303M 283M 267M 491M 32.26B 536M 3.31B 1.28B 15.21B 1.34B 1.31B 55.48B |
| Net income | 206M 29.13M 24.81M 23.18M 21.81M 40.15M 2.64B 43.86M 271M 105M 1.24B 109M 107M 4.54B | 238M 33.66M 28.68M 26.79M 25.2M 46.4M 3.05B 50.69M 313M 121M 1.44B 126M 124M 5.24B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 13.41 ¥ | +0.83% | 2,004,349 |
| 25-12-11 | 13.30 ¥ | -1.48% | 1,911,647 |
| 25-12-10 | 13.50 ¥ | -0.44% | 1,553,362 |
| 25-12-09 | 13.56 ¥ | -0.88% | 1,943,552 |
| 25-12-08 | 13.68 ¥ | 0.00% | 1,959,865 |
End-of-day quote Shanghai S.E., December 11, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688315 Stock
Select your edition
All financial news and data tailored to specific country editions
